We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Team Determines Dose Threshold That Increases Delivery of Anticancer Drugs

News   Aug 11, 2020 | Original story from University of Toronto

 
Team Determines Dose Threshold That Increases Delivery of Anticancer Drugs
 
 
Advertisement
 

RELATED ARTICLES

Study Finds THC Can Help Prevent Colon Cancer in Mice

News

Tetrahydrocannabinol (THC) may be able to prevent the development of colon cancers, say researchers from the University of South Carolina.

READ MORE

CD19 in Brain Cells May Be Cause of Immunotherapy-Related Neurotoxicity

News

New research has uncovered the presence of CD19 -- a B cell molecule targeted by chimeric antigen receptor (CAR) T cell immunotherapy to treat leukemia, lymphoma, and multiple myeloma -- in brain cells that protect the blood brain barrier (BBB).

READ MORE

Insights Into Therapeutic Mechanisms of Cancer Drug Pomalidomide

News

Researchers report novel findings concerning the therapeutic mechanisms of pomalidomide. They showed that pomalidomide causes the breakdown of a protein called ARID2. ARID2 promotes the "expression" of genes that are critical for the growth of multiple myeloma cells, so breaking down ARID2 is harmful to the cancer cells and beneficial to patients.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Applied Sciences Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE